Like DoctorsForMe, Inc.

closed 1/15/2020 via BusinessWire

Human Longevity, Inc., acquired DoctorsForMe, Inc.

synopsis: Human Longevity, Inc., a provider of data-driven health intelligence and precision health to physicians and patients, has acquired DoctorsForMe, Inc, a company that helps patients find the right physician by analyzing billions of data points about doctors using big data and artificial intelligence technologies.
buyer: Human Longevity, Inc.
Human Longevity provides unparalleled, precision health analytics to individuals through the Health Nucleus. The Health Nucleus provides an assessment of current and future risk for cardiac, oncologic, metabolic, and cognitive diseases and conditions. "
target: DoctorsForMe, Inc.
DoctorsForMe helps patients with complex conditions find the right doctors when they need them most. DoctorsForMe measures a doctor's expertise and clinical excellence by analyzing billions of data points about doctors using big data and artificial intelligence technologies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/15/2020 via BusinessWire

Human Longevity, Inc., acquired DoctorsForMe, Inc.

synopsis: Human Longevity, Inc., a provider of data-driven health intelligence and precision health to physicians and patients, has acquired DoctorsForMe, Inc, a company that helps patients find the right physician by analyzing billions of data points about doctors using big data and artificial intelligence technologies.
buyer: Human Longevity, Inc.
Human Longevity provides unparalleled, precision health analytics to individuals through the Health Nucleus. The Health Nucleus provides an assessment of current and future risk for cardiac, oncologic, metabolic, and cognitive diseases and conditions. "
target: DoctorsForMe, Inc.
DoctorsForMe helps patients with complex conditions find the right doctors when they need them most. DoctorsForMe measures a doctor's expertise and clinical excellence by analyzing billions of data points about doctors using big data and artificial intelligence technologies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/15/2020 via BusinessWire

Human Longevity, Inc., acquired DoctorsForMe, Inc.

synopsis: Human Longevity, Inc., a provider of data-driven health intelligence and precision health to physicians and patients, has acquired DoctorsForMe, Inc, a company that helps patients find the right physician by analyzing billions of data points about doctors using big data and artificial intelligence technologies.
buyer: Human Longevity, Inc.
Human Longevity provides unparalleled, precision health analytics to individuals through the Health Nucleus. The Health Nucleus provides an assessment of current and future risk for cardiac, oncologic, metabolic, and cognitive diseases and conditions. "
target: DoctorsForMe, Inc.
DoctorsForMe helps patients with complex conditions find the right doctors when they need them most. DoctorsForMe measures a doctor's expertise and clinical excellence by analyzing billions of data points about doctors using big data and artificial intelligence technologies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/30/2015 via PR Newswire

Human Longevity, Inc., acquired Cypher Genomics

synopsis: Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced that the company has acquired Cypher Genomics, Inc., a leading genome informatics company offering highly accurate, rapid and robust human genomic interpretation software solutions.
buyer: Human Longevity, Inc.
Human Longevity, Inc. (HLI) is the genomics-based, technology-driven company creating the world's largest database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and learning to make novel discoveries to revolutionize the practice of medicine. "
target: Cypher Genomics
Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2016 via GlobeNewswire

Aptean, acquired GQ Life Sciences, Inc

synopsis: Aptean, a leading provider of mission critical enterprise software solutions that help 6,500 organizations stay at the forefront of their industries, announced the acquisition of GQ Life Sciences, Inc., a global provider of life science patent search solutions including SaaS-based search capabilities.
buyer parent: Vista Equity Partners
buyer: Aptean
Aptean is a leading provider of mission critical enterprise software solutions. Their solutions help nearly 5,000 organizations stay at the forefront of their industries by enabling them to operate more efficiently, thereby ensuring higher customer satisfaction. "
target parent: Milestone Venture Partners
target: GQ Life Sciences, Inc
GQ Life Sciences, Inc. is a global life science information and search company and the market leader in biological sequence comparison. GQ Life Sciences is proud to offer its second major product, LifeQuest, alongside its flagship GenomeQuest software.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2012 via BusinessWire

LifeMap Sciences, Inc., acquired XenneX, Inc.

synopsis: BioTime, Inc. and its wholly owned subsidiary, LifeMap Sciences, announced that they have completed the acquisition of XenneX, Inc. through a merger of XenneX into LifeMap Sciences. XenneX provides biotechnology, pharmaceutical and other life sciences companies, services and tools to enhance their bio-medical research.
buyer parent: BioTime, Inc.
buyer: LifeMap Sciences, Inc.
LifeMap Sciences, Inc. is developing a discovery platform, including a web-based database, to aid researchers in the use of embryonic stem cells, progenitor cells, and induced pluripotent stem cells for the development of new products and technologies in the emerging field of regenerative medicine. "
target: XenneX, Inc.
XenneX, Inc. is a privately held company that is dedicated to providing biotechnology, pharmaceutical and other life sciences companies, as well as organizations dealing with biotechnology intellectual property, the highest level of services and tools to enhance their bio-medical research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/29/2010 via PR Newswire

Thomson Scientific & Healthcare, acquired GeneGo Inc.

synopsis: Thomson Reuters announced that it has acquired GeneGo, a leading provider of biology and disease information, analytics, and decision support solutions for pharmaceutical research and development. Effective immediately, GeneGo will become part of the Healthcare & Science business of Thomson Reuters.
buyer parent: Thomson Reuters
buyer: Thomson Scientific & Healthcare (:$964.58)
Thomson Scientific & Healthcare provides integrated information solutions to researchers and librarians, physicians and pharmacists, and other professionals worldwide. "
target: GeneGo Inc.
GeneGo is a leading provider of data mining & analysis solutions in systems biology. GeneGo's data mining tools and databases help to capture and define the underlying biology behind different types of high-throughput experimental data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/18/2013 via BNC Analysis

Therapeutic Research Center, Inc., acquired Natural Standard

synopsis: Therapeutic Research Center (TRC), has announced that it has acquired Natural Standard, the authority on evidence-based, peer-reviewed information about dietary supplements, complementary and alternative medicine (CAM) practices including modalities, special diets, and exercises.
buyer parent: Francisco Partners Management LLC
buyer: Therapeutic Research Center, Inc.
Therapeutic Research Center is a research, analytic, and information services organization that provides evidence-based drug therapy recommendations for physicians, pharmacists, pharmacy technicians, and other healthcare professionals. "
target: Natural Standard
Natural Standard was founded by healthcare providers and researchers to provide high-quality, evidence-based information about complementary and alternative medicine including dietary supplements and integrative therapies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like DoctorsForMe, Inc.


read more

DoctorsForMe, Inc.

read more

DoctorsForMe, Inc.

read more

DoctorsForMe, Inc.

Cypher Genomics

read more

GQ Life Sciences, Inc

XenneX, Inc.

GeneGo Inc.

Natural Standard

Geography
Matching Companies
Ticker: AIM:CRON
 
 
 
 
 
 
 
 
Cronin Group PLC
Cronin Group PLC provides medical research and development services. The Company focuses on the discovery, development, and manufacture of small molecules and nano-materials utilizing proprietary chemistry. Cronin Group offers its services in the United Kingdom.
year
2018
rev ($mm)
EBITDA ($mm)
($2.29)
EBIT ($mm)
($2.34)
Net Income ($mm)
Employees
25
  • drill down
  • watch
Ticker: ENXTPA:CGM
 
 
 
 
 
 
 
 
Cegedim
Cegedim
Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases.
year
2018
rev ($mm)
$512.82
EBITDA ($mm)
$50.20
EBIT ($mm)
$33.91
Net Income ($mm)
$6.33
Employees
4468
  • drill down
  • watch